Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Injectable biomaterials

一种注射组合物、物质的技术，应用在原弹性蛋白领域，能够解决团不能递送、没有具有高固含量等问题

Active Publication Date: 2012-02-08
APTALIS PHARMA
View PDF6 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although microparticles formed from biological materials are mentioned in WO99 / 11196 and WO2008 / 058323, there are no compositions of smaller particle structures with high solids content of such proteins and sufficient flow properties for tissue delivery by injection
One problem is that when the solids content is high, the boluses formed by tropoelastin cannot be delivered through the various gauge needles used in clinical and cosmetic applications

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Injectable biomaterials
  • Injectable biomaterials
  • Injectable biomaterials

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0113] Example 1: Production of spheres formed from tropoelastin at low tropoelastin concentrations using basic polymerization

[0114] Materials and methods

[0115] 20 mg of tropoelastin was dissolved in 10 mL of phosphate buffered saline (PBS) at 4°C overnight (estimated 16 hours) to provide a final concentration of tropoelastin of 2 mg / ml. Keep the solution on ice throughout the process, measure the initial pH of the solution (pH 7.2), and adjust the pH of the solution to 10.7 by adding 39 μL of 1 M NaOH. Then, the resulting solution was incubated in a 15 mL tube at 37°C for 4 hours, after which it was removed from the incubator and left at room temperature.

[0116] result

[0117] The resulting microparticles tend to coat the tube walls. SEM images of solution samples ( Figure 1A ) shows that the microparticles present have an estimated diameter of 1 μm. Due to the "sticky" nature of the elastic material, the balls tend to clump together.

Embodiment 2

[0118] Example 2: Alkaline polymerization of tropoelastin at a concentration of 10 mg / ml in the absence of coalescence controlling agents

[0119] Materials and methods

[0120] Dissolve 50 mg of tropoelastin in 4.9 mL of PBS overnight at 4°C (estimated 16 hours). Keep the solution on ice throughout the process, measure the initial pH of the solution (pH 7.22), and adjust the solution pH to 10.7 by adding 47 μL of 1 M NaOH. Add an additional 53 µL of PBS to make a final concentration of tropoelastin solution of 10 mg / mL. The solution was then incubated overnight (16 hours) at 37°C in a 5 mL flat-bottomed tube, after which it was removed from the incubator and left at room temperature.

[0121] result

[0122] From Figure 1B As can be seen in , the resulting material is a solid elastic material that retains its fabricated tube shape. More than 4.5 mL of liquid was separated from the resulting solid, indicating that the majority (>40 mg) of the 50 mg tropoelastin was p...

Embodiment 3

[0123] Example 3: Production of pellets in the presence of CMC as coalescence control agent using chemical crosslinking

[0124] Materials and methods

[0125] A 200 mg / mL tropoelastin stock solution was obtained by dissolving 300 mg tropoelastin in 1.5 mL PBS overnight at 4°C. A 2% (w / v) stock solution of high viscosity carboxymethylcellulose (CMC; Sigma Cat. No. C5013) was obtained by dissolving 2 g of CMC in 100 mL of PBS and stirring overnight at room temperature.

[0126] The solution was kept on ice throughout the process, and 250 μL of the tropoelastin stock solution was mixed with 200 μL of PBS and 500 μL of 2% (weight / volume) CMC. A new tube of 25% (v / v) glutaraldehyde (GA) solution was opened on ice, and 2 μL of 25% (v / v) GA was mixed with 48 μL of PBS and immediately added to the tropoelastin solution. The resulting mixture of 50 mg / mL tropoelastin, 1% (w / v) CMC, 0.05% (v / v) GA was stirred with a cooled pipette tip (pre-cool the pipette tip by standing overnight...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Injectable biomaterial compositions formed from tropoelastin for tissue repair and restoration. The compositions include a coalescence-controlling agent in the form of a polysaccharide or polysaccharide derivative, in an amount effective for providing the substance with the properties of flow, enabling injection.

Description

technical field [0001] The present invention relates to tropoelastin and to the use of biomaterials for tissue repair and restoration. Background technique [0002] Elastin is an extracellular matrix protein found primarily in the skin, blood vessels, lungs, and other tissues and organs that require a certain degree of elasticity to function. It usually forms by cross-linking lysine residues on tropoelastin molecules with lysine residues on other tropoelastin molecules, forming clusters that are nearly insoluble in aqueous solutions. [0003] Elastin, tropoelastin, and related proteins are expected to be useful in medical applications including tissue repair and restoration, and there is a particular need for compositions of such proteins with high solids content that can be administered to tissue by injection. Although microparticles formed from biological materials are mentioned in WO99 / 11196 and WO2008 / 058323, there are no compositions of smaller particle structures with...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K38/39A61L27/22C07K14/78A61K47/36C07K14/435
CPCA61K9/0019A61L27/20A61L2400/06C07K14/78A61K38/39A61K9/16C08L1/02
Inventor 安托尼·史蒂文·魏斯苏珊娜·玛丽·米蒂厄
Owner APTALIS PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com